← Back to Research← 返回研究
BMYEarnings ReleaseSource checkedAugust 3, 2026by InvestLog AI

BMY earnings release — EPS beat +27.5% · revenue beat +10.5%百时美施贵宝 (BMY) 财报发布 — EPS 高于预期+27.5% · 营收 高于预期+10.5%

Key Results

Bristol-Myers Squibb Company (BMY) published results at 2026-07-30 06:59:00.

Actual vs Consensus

  • EPS: $2.04 vs $1.60 estimate, beat+27.5%.
  • Revenue: $13.0B vs $11.7B estimate, beat+10.5%.
  • Profitability and Cash Flow

  • Period: 2026 Q2 period ended 2026-06-30
  • Revenue: $13.0B; YoY: +12.9%
  • Gross profit: $9.2B; Gross margin: 71.3%
  • Operating income: $4.1B; Operating margin: 31.5%
  • Net income: $3.3B; GAAP diluted EPS: $1.62
  • Operating cash flow: $3.4B; Capex: $305M; Free cash flow: $3.1B
  • Cash: $8.7B; Total debt: $43.1B; Net debt: $34.4B
  • Official release: Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

    核心结果

    百时美施贵宝 (BMY) 已发布财报,发布时间:2026-07-30 06:59:00。

    实际值与市场预期

  • EPS:$2.04 vs $1.60 预期,高于预期+27.5%。
  • 营收:$13.0B vs $11.7B 预期,高于预期+10.5%。
  • 利润与现金流

  • 期间:2026 Q2 period ended 2026-06-30
  • 营收:$13.0B;同比:+12.9%
  • 毛利润:$9.2B;毛利率:71.3%
  • 经营利润:$4.1B;经营利润率:31.5%
  • 净利润:$3.3B;GAAP 稀释 EPS:$1.62
  • 经营现金流:$3.4B;资本开支:$305M;自由现金流:$3.1B
  • 现金:$8.7B;总债务:$43.1B;净债务:$34.4B
  • 官方公告:Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

    This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考,不构成投资建议。